Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Lin, Tzu Yin ^a   Zhang, Hongyong ^a   Wang, Sisi ^a,b   Xie, Li ^a   Li, Bin ^a,c   Rodriguez Jr, Carlos O ^d   de Vere White, Ralph ^a   Pan, Chong Xian ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Basic Medical College   (China)

^c Unit 3   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; FLUORESCENT DYE CY5.5; LIGAND; ONCOPROTEIN; PROTEIN PLZ4; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CYCLOPEPTIDE; OLIGOPEPTIDE; PLZ4 PEPTIDE;

AFFINITOFLUORESCENCE ASSAY; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BLADDER; BLADDER CANCER; BLADDER CARCINOMA; BLADDER TRANSITIONAL CELL CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL HOMING; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOG; EX VIVO STUDY; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; INCUBATION TIME; INJECTION; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; OPTICAL TOMOGRAPHY; PROTEIN BINDING; TRANSITIONAL CELL CARCINOMA; TUMOR XENOGRAFT; UROTHELIUM; VEIN; WHOLE CELL; ANIMAL; ANIMAL DISEASE; BLADDER TUMOR; CANCER TRANSPLANTATION; CELL SURVIVAL; DOG DISEASE; DRUG EFFECT; PATHOLOGY; TUMOR CELL CULTURE; XENOGRAFT;

CANIS FAMILIARIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CELL SURVIVAL; DOG DISEASES; DOGS; HUMANS; LIGANDS; MICE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; PEPTIDES, CYCLIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 79251561536     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-9     Document Type: Article

References (9)

1. Zhang H, Aina OH, Lam KS, de Vere White R, Evans C, Henderson P, Lara PN, Wang X, Bassuk JA, Pan CX. Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach. Urol Oncol 2010,
2. Deborah WK, Nita WG, Dennis BD, Patty LB, Tsang LL, Lawrence TG. Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer. Urologic oncology 2000, 5:47-59. 10.1016/S1078-1439(99)00006-X, 21227289.
3. Dhawan D, Ramos-Vara JA, Stewart JC, Zheng R, Knapp DW. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer. Urol Oncol 2009, 27:284-292.
4. Patrick DJ, Fitzgerald SD, Sesterhenn IA, Davis CJ, Kiupel M. Classification of canine urinary bladder urothelial tumours based on the World Health Organization/International Society of Urological Pathology consensus classification. J Comp Pathol 2006, 135:190-199. 10.1016/j.jcpa.2006.07.002, 17054974.
5. Mutsaers AJ, Widmer WR, Knapp DW. Canine transitional cell carcinoma. J Vet Intern Med 2003, 17:136-144. 10.1111/j.1939-1676.2003.tb02424.x, 12683611.
6. Norris AM, Laing EJ, Valli VE, Withrow SJ, Macy DW, Ogilvie GK, Tomlinson J, McCaw D, Pidgeon G, Jacobs RM. Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med 1992, 6:145-153. 10.1111/j.1939-1676.1992.tb00330.x, 1619591.
7. Peng L, Liu R, Marik J, Wang X, Takada Y, Lam KS. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging. Nat Chem Biol 2006, 2:381-389. 10.1038/nchembio798, 16767086.
8. Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 2005, 174:2134-2137. 10.1097/01.ju.0000181799.81119.fc, 16280743.
9. Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, Loening SA, Schnorr D. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005, 174:2129-2133. discussion 2133, 10.1097/01.ju.0000181814.73466.14, 16280742.